Anmelden

Publikationen

Suche in 12964 Publikationen:

Zurücksetzen RSS
Zeitraum
12964 Publikation(en)
06.12.2023
Probiotika in der Gastroenterologie
Kueres-Wiese A, Vavricka S, Baumann P. Probiotika in der Gastroenterologie. Swiss Med Forum 2023; 2023:1482-1487.
06.12.2023
Probiotika in der Gastroenterologie
06.12.2023

Swiss Med Forum 2023; 2023:1482-1487

Kueres-Wiese Alexander, Vavricka Stephan R, Baumann Philippe

Weiter
05.12.2023
A replicating LCMV-based vaccine for the treatment of solid tumors.
Purde M, Cupovic J, Palmowski Y, Makky A, Schmidt S, Rochwarger A, Hartmann F, Stemeseder F, Lercher A, Abdou M, Bomze D, Besse L, Berner F, Tüting T, Hölzel M, Bergthaler A, Kochanek S, Ludewig B, Lauterbach H, Orlinger K, Bald T, Schietinger A, Schürch C, Ring S, Flatz L. A replicating LCMV-based vaccine for the treatment of solid tumors. Mol Ther 2023
05.12.2023
A replicating LCMV-based vaccine for the treatment of solid tumors.
05.12.2023

Mol Ther 2023

Purde Mette-Triin, Cupovic Jovana, Palmowski Yannick A, Makky Ahmad, Schmidt Sarah, Rochwarger Alexander, Hartmann Fabienne, Stemeseder Felix, Lercher Alexander, Abdou Marie-Therese, Bomze David, Besse Lenka, Berner Fiamma, Tüting Thomas, Hölzel Michael, Bergthaler Andreas, Kochanek Stefan, Ludewig Burkhard, Lauterbach Henning, Orlinger Klaus K, Bald Tobias, Schietinger Andrea, Schürch Christian M, Ring Sandra Stephanie, Flatz Lukas

Weiter
05.12.2023
Survey in radiation oncology departments in Germany, Austria, and Switzerland: state of digitalization by 2023.
Janssen S, Stahel R, Grohmann M, Knippen S, Putora P, Beck M, Baehr A, Clemens P, Stefanowicz S, Rades D, Becker J, Fahlbusch F. Survey in radiation oncology departments in Germany, Austria, and Switzerland: state of digitalization by 2023. Strahlenther Onkol 2023
05.12.2023
Survey in radiation oncology departments in Germany, Austria, and Switzerland: state of digitalization by 2023.
05.12.2023

Strahlenther Onkol 2023

Janssen Stefan, Stahel Rolf A, Grohmann Maximilian, Knippen Stefan, Putora Paul Martin, Beck Marcus, Baehr Andrea, Clemens Patrick, Stefanowicz Sarah, Rades Dirk, Becker Jan-Niklas, Fahlbusch Fabian B

Weiter
05.12.2023
Hämorrhoidenarterienligatur mit Mukopexie vs. Hämorrhoidektomie nach Ferguson
Bischofberger S, Gingert C. Hämorrhoidenarterienligatur mit Mukopexie vs. Hämorrhoidektomie nach Ferguson - Rezidivrate und Lebensqualität. coloproctology 2023
05.12.2023
Hämorrhoidenarterienligatur mit Mukopexie vs. Hämorrhoidektomie nach Ferguson
05.12.2023

coloproctology 2023

Bischofberger Stephan, Gingert Christian

Weiter
04.12.2023
Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes.
Megat S, Mora N, Sanogo J, Roman O, Catanese A, Alami N, Freischmidt A, Mingaj X, De Calbiac H, Muratet F, Dirrig-Grosch S, Dieterle S, Van Bakel N, Müller K, Sieverding K, Weishaupt J, Andersen P, Weber M, Neuwirth C, Margelisch M, Sommacal A, van Eijk K, Veldink J, PROJECT MINE ALS SEQUENCING CONSORTIUM, Lautrette G, Couratier P, Camuzat A, Le Ber I, Grassano M, Chio A, Boeckers T, Ludolph A, Roselli F, Yilmazer-Hanke D, Millecamps S, Kabashi E, Storkebaum E, Sellier C, Dupuis L. Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes. Nat Commun 2023; 14:8026.
04.12.2023
Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes.
04.12.2023

Nat Commun 2023; 14:8026

Megat Salim, Mora Natalia, Sanogo Jason, Roman Olga, Catanese Alberto, Alami Najwa Ouali, Freischmidt Axel, Mingaj Xhuljana, De Calbiac Hortense, Muratet François, Dirrig-Grosch Sylvie, Dieterle Stéphane, Van Bakel Nick, Müller Kathrin, Sieverding Kirsten, Weishaupt Jochen H, Andersen Peter Munch, Weber Markus, Neuwirth Christoph, Margelisch Markus, Sommacal Andreas, van Eijk Kristel R, Veldink Jan H, PROJECT MINE ALS SEQUENCING CONSORTIUM, Lautrette Géraldine, Couratier Philippe, Camuzat Agnès, Le Ber Isabelle, Grassano Maurizio, Chio Adriano, Boeckers Tobias, Ludolph Albert C., Roselli Francesco, Yilmazer-Hanke Deniz, Millecamps Stéphanie, Kabashi Edor, Storkebaum Erik, Sellier Chantal, Dupuis Luc

Weiter
04.12.2023
Tacrolimus monitoring in hair samples of kidney transplant recipients.
Born A, Bocchi F, Kuhn C, Amstutz U, Baumgartner M, Sidler D. Tacrolimus monitoring in hair samples of kidney transplant recipients. Front Med (Lausanne) 2023; 10:1307505.
04.12.2023
Tacrolimus monitoring in hair samples of kidney transplant recipients.
04.12.2023

Front Med (Lausanne) 2023; 10:1307505

Born Alexander, Bocchi Federica, Kuhn Christian, Amstutz Ursula, Baumgartner Matthias R, Sidler Daniel

Weiter
02.12.2023
The German version of the tablet-based UCSF Brain Health Assessment is sensitive to early symptoms of neurodegenerative disorders.
Gianina T, Lorena S, Dilaxy K, Patrick C, Florian K, Münzer T, Kunze U, Andreas U, Kate P, Rankin K, Felbecker A. The German version of the tablet-based UCSF Brain Health Assessment is sensitive to early symptoms of neurodegenerative disorders. Brain Behav 2023:e3329.
02.12.2023
The German version of the tablet-based UCSF Brain Health Assessment is sensitive to early symptoms of neurodegenerative disorders.
02.12.2023

Brain Behav 2023:e3329

Gianina Toller, Lorena Stäger, Dilaxy Kumurasamy, Patrick Callahan, Florian Köhn, Münzer Thomas, Kunze Ursi, Andreas U Monsch, Kate Possin, Rankin Katherine P, Felbecker Ansgar

Weiter
01.12.2023
Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Neubauer M, Nicolas G, Bauman A, Fani M, Nitzsche E, Afshar-Oromieh A, Forrer F, Rentsch C, Stenner-Liewen F, Templeton A, Schäfer N, Wild D, Chirindel A, all investigators on behalf of the SSNM Therapy Working Group. Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study. Eur J Nucl Med Mol Imaging 2023
01.12.2023
Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
01.12.2023

Eur J Nucl Med Mol Imaging 2023

Neubauer Moritz C, Nicolas Guillaume, Bauman Andreas, Fani Melpomeni, Nitzsche Egbert U, Afshar-Oromieh Ali, Forrer Flavio, Rentsch Cyrill A, Stenner-Liewen Frank, Templeton Arnoud J, Schäfer Niklaus G, Wild Damian, Chirindel Alin, all investigators on behalf of the SSNM Therapy Working Group

Weiter
01.12.2023
Protective fibroblastic niches in secondary lymphoid organs.
De Martin A, Stanossek Y, Pikor N, Ludewig B. Protective fibroblastic niches in secondary lymphoid organs. J Exp Med 2023; 221
01.12.2023
Protective fibroblastic niches in secondary lymphoid organs.
01.12.2023

J Exp Med 2023; 221

De Martin Angelina, Stanossek Yves, Pikor Natalia Barbara, Ludewig Burkhard

Weiter
01.12.2023
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single institutional cohort study.
Wagner N, Knierim S, Luttermann F, Metzler G, Yazdi A, Bauer J, Gassenmaier M, Forschner A, Leiter U, Amaral T, Garbe C, Eigentler T, Forchhammer S, Flatz L. Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single institutional cohort study. J Am Acad Dermatol 2023
01.12.2023
Histopathologic regression in patients with primary cutaneous melanoma undergoing sentinel lymph node biopsy is associated with favorable survival and, after metastasis, with improved progression-free survival on immune checkpoint inhibitor therapy: A single institutional cohort study.
01.12.2023

J Am Acad Dermatol 2023

Wagner Nikolaus, Knierim Sarah M, Luttermann Felix, Metzler Gisela, Yazdi Amir Sadegh, Bauer Jürgen, Gassenmaier Maximilian, Forschner Andrea, Leiter Ulrike, Amaral Teresa, Garbe Claus, Eigentler Thomas Kurt, Forchhammer Stephan, Flatz Lukas

Weiter
01.12.2023
[Urinary retention in young female patients].
Abgottspon D, Hornung R, Hülder T, Greive L. [Urinary retention in young female patients]. Praxis (Bern 1994) 2023; 112:656-658.
01.12.2023
[Urinary retention in young female patients].
01.12.2023

Praxis (Bern 1994) 2023; 112:656-658

Abgottspon Désirée, Hornung René, Hülder Tanja, Greive Larissa

Weiter
01.12.2023
[Lipid Management in Practice].
Dehos B, Bilz S. [Lipid Management in Practice]. Praxis (Bern 1994) 2023; 112:649-654.
01.12.2023
[Lipid Management in Practice].
01.12.2023

Praxis (Bern 1994) 2023; 112:649-654

Dehos Barbara, Bilz Stefan

Weiter
01.12.2023
[Modern endoscopy in inflammatory bowel disease].
Truniger S, Frei R, Brand S. [Modern endoscopy in inflammatory bowel disease]. Ther Umsch 2023; 80:411-416.
01.12.2023
[Modern endoscopy in inflammatory bowel disease].
01.12.2023

Ther Umsch 2023; 80:411-416

Truniger Samuel, Frei Remus, Brand Stephan

Weiter
01.12.2023
Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology.
Wiegand N, Geyer M, Lollo G, Wuillemin W, Aepli P, Frei R, Godat S, Manz M, Seewald S, The F, Wiest R, Borovicka J, Brand S, Buyse S, Degen L, Ehmann T, Riniker F, Riva D, Semela D, Truninger K, Utzinger E, Vonlaufen A. Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology. Praxis (Bern 1994) 2023; 112:635-641.
01.12.2023
Antithrombotic therapy and assessment for bleeding diathesis in elective gastrointestinal endoscopy - Expert Opinion Statement on behalf of the Swiss Society of Gastroenterology.
01.12.2023

Praxis (Bern 1994) 2023; 112:635-641

Wiegand Nico, Geyer Martin, Lollo Gianluca, Wuillemin W A, Aepli Patrick, Frei Remus, Godat Sébastien, Manz Michael, Seewald Stefan, The Frans Olivier, Wiest Reiner, Borovicka Jan, Brand Stephan, Buyse Sophie, Degen Lukas, Ehmann Tobias, Riniker Florian, Riva Daniele, Semela David, Truninger Kaspar, Utzinger Ellen, Vonlaufen Alain

Weiter
01.12.2023
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.
Ciurea A, Götschi A, Bräm R, Bürki K, Exer P, Andor M, Nissen M, Möller B, Hügle T, Rubbert-Roth A, Kyburz D, Distler O, Scherer A, Micheroli R. Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry. RMD Open 2023; 9
01.12.2023
Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry.
01.12.2023

RMD Open 2023; 9

Ciurea Adrian, Götschi Andrea, Bräm René, Bürki Kristina, Exer Pascale, Andor Michael, Nissen Michael J, Möller Burkhard, Hügle Thomas, Rubbert-Roth Andrea, Kyburz Diego, Distler Oliver, Scherer Almut, Micheroli Raphael

Weiter
30.11.2023
Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma.
Nübel C, Amaral T, Leiter U, Flatz L, Forschner A. Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma. Front Oncol 2023; 13:1256800.
30.11.2023
Outcome and treatment-related adverse events of combined immune checkpoint inhibition with flipped dosing in a real-world cohort of 79 patients with metastasized melanoma.
30.11.2023

Front Oncol 2023; 13:1256800

Nübel Charlotte, Amaral Teresa, Leiter Ulrike, Flatz Lukas, Forschner Andrea

Weiter
30.11.2023
Psychische Störungen nach Schädelhirntrauma
Schmidt R (2023). Psychische Störungen nach Schädelhirntrauma. Präsentiert bei: DGPPN 2023, Berlin, Deutschland
30.11.2023
Psychische Störungen nach Schädelhirntrauma
30.11.2023

DGPPN 2023

Schmidt Roger

Weiter
30.11.2023
Surgical site infections after kidney transplantation are independently associated with graft loss.
Schreiber P, Hoessly L, Boggian K, Neofytos D, Van Delden C, Egli A, Dickenmann M, Hirzel C, Manuel O, Koller M, Rossi S, Banz V, Schmied B, Gürke L, Matter M, de Rougemont O, Bonani M, Golshayan D, Schnyder A, Sidler D, Haidar F, Kuster S, Stampf S, Müller N, members of the Swiss Transplant Cohort Study (STCS). Surgical site infections after kidney transplantation are independently associated with graft loss. Am J Transplant 2023
30.11.2023
Surgical site infections after kidney transplantation are independently associated with graft loss.
30.11.2023

Am J Transplant 2023

Schreiber Peter W, Hoessly Linard D, Boggian Katia, Neofytos Dionysios, Van Delden Christian, Egli Adrian, Dickenmann Michael, Hirzel Cédric, Manuel Oriol, Koller Michael, Rossi Simona, Banz Vanessa M, Schmied Bruno, Gürke Lorenz, Matter Maurice, de Rougemont Olivier, Bonani Marco, Golshayan Délaviz, Schnyder Aurelia, Sidler Daniel, Haidar Fadi, Kuster Stefan, Stampf Susanne, Müller Nicolas J., members of the Swiss Transplant Cohort Study (STCS)

Weiter
29.11.2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
Bauer T, Santoro A, Lin C, Garrido-Laguna I, Jörger M, Greil R, Spreafico A, Yau T, Goebeler M, Hütter-Krönke M, Perotti A, Juif P, Lu D, Barys L, Cremasco V, Pelletier M, Evans H, Fabre C, Doi T. Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors. J Immunother Cancer 2023; 11
29.11.2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
29.11.2023

J Immunother Cancer 2023; 11

Bauer Todd M, Santoro Armando, Lin Chia-Chi, Garrido-Laguna Ignacio, Jörger Markus, Greil Richard, Spreafico Anna, Yau Thomas, Goebeler Maria-Elisabeth, Hütter-Krönke Marie Luise, Perotti Antonella, Juif Pierre-Eric, Lu Darlene, Barys Louise, Cremasco Viviana, Pelletier Marc, Evans Helen, Fabre Claire, Doi Toshikiko

Weiter
29.11.2023
Funktionelle neurologische Störungen in der Psychiatrie – blinder Fleck und Chance zugleich?
Schmidt R (2023). Funktionelle neurologische Störungen in der Psychiatrie – blinder Fleck und Chance zugleich?. Präsentiert bei: DGPPN 2023, Berlin, Deutschland
29.11.2023
Funktionelle neurologische Störungen in der Psychiatrie – blinder Fleck und Chance zugleich?
29.11.2023

DGPPN 2023

Schmidt Roger

Weiter

Wir verwenden Cookies und Tracking-Technologien gemäss unserer Datenschutz- bestimmungen, um Ihnen die bestmögliche Web-Erfahrung zu ermöglichen. Zur Datenschutzerklärung